Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histiocytic Disorder Follow-up Study

NCT05915208 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT05915208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05915208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histiocytic Disorder Follow-up Study
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2022
Completion date
December 31, 2028
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erdheim-chester disease, histiocytosis, langerhans cell histiocytosis, malignant histiocytoses, rosai dorfman disease, xanthogranuloma